JANE STREET GROUP, LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 72 filers reported holding LEAP THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,403
-95.8%
10,008
-94.5%
0.00%
Q4 2022$81,524
-29.1%
181,164
+38.2%
0.00%
Q3 2022$115,000
+161.4%
131,113
+424.5%
0.00%
Q1 2022$44,000
-20.0%
25,000
+46.2%
0.00%
Q4 2021$55,000
+150.0%
17,100
+60.8%
0.00%
Q2 2020$22,00010,6370.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
683 Capital Management, LLC 150,142$268,0000.02%
Alyeska Investment Group, L.P. 514,285$921,0000.01%
A.R.T. Advisors, LLC 15,461$28,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 36,300$65,0000.00%
Lindbrook Capital, LLC 1,500$2,0000.00%
US BANCORP \DE\ 6,100$11,0000.00%
Asset Planning Services, Ltd. 100$00.00%
FMR LLC 1,563,124$2,798,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 164,493$294,0000.00%
View complete list of LEAP THERAPEUTICS INC shareholders